Vascular Inflammation as a Therapeutic Target in COVID-19 “Long Haulers”: HIITing the Spot?
Regitse Højgaard Christensen1,2*Ronan M. G. Berg1,3,4,5 Background In the wake of the first wave of the ongoing global pandemic, it has become imminently clear that coronavirus disease 2019 (COVID-19) has brought with it a whole new clinical syndrome: “long COVID” (1, 2). Hence, after recovery from the acute viral infection, a remarkably large proportion of patients, […]